10/15/2024 | Press release | Distributed by Public on 10/15/2024 14:09
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||
|
1. Title of Derivate Security | 2. Date Exercisable and Expiration Date | 3. Title and Amount of Securities Underlying Derivative Security | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) | 6. Nature of Indirect Beneficial Ownership |
Date Exercisable | Expriation Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Cormorant Asset Management, LP 200 CLARENDON STREET 52ND FLOOR BOSTON, MA02116 |
|
|
|
|
Cormorant Global Healthcare Master Fund, LP 200 CLARENDON STREET 52ND FLOOR BOSTON, MA02116 |
|
|
|
|
Cormorant Private Healthcare Fund III LP 200 CLARENDON STREET 52ND FLOOR BOSTON, MA02116 |
|
|
|
|
Cormorant Private Healthcare Fund IV LP 200 CLARENDON STREET 52ND FLOOR BOSTON, MA02116 |
|
|
|
|
Cormorant Private Healthcare Fund V LP 200 CLARENDON STREET 52ND FLOOR BOSTON, MA02116 |
|
|
|
|
Chen Bihua C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON, MA02116 |
|
|
|
|
CORMORANT ASSET MANAGEMENT, LP By: /s/ Bihua Chen, Managing Member | 2024-10-15 |
**Signature of Reporting Person | Date |
CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP By: Cormorant Global Healthcare GP, LLC, its General Partner By: /s/ Bihua Chen, Managing Member | 2024-10-15 |
**Signature of Reporting Person | Date |
CORMORANT PRIVATE HEALTHCARE FUND III, LP By: Cormorant Private Healthcare GP III, LLC, its General Partner By: /s/ Bihua Chen, Managing Member | 2024-10-15 |
**Signature of Reporting Person | Date |
CORMORANT PRIVATE HEALTHCARE FUND IV, LP By: Cormorant Private Healthcare GP IV, LLC, its General Partner By: /s/ Bihua Chen, Managing Member | 2024-10-15 |
**Signature of Reporting Person | Date |
CORMORANT PRIVATE HEALTHCARE FUND V, LP By: Cormorant Private Healthcare GP V, LLC, its General Partner By: /s/ Bihua Chen, Managing Member | 2024-10-15 |
**Signature of Reporting Person | Date |
/s/ Bihua Chen | 2024-10-15 |
**Signature of Reporting Person | Date |
(*) | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
(**) | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Cormorant Asset Management, LP serves as the investment manager to Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund III, LP ("Fund III"), Cormorant Private Healthcare Fund IV, LP ("Fund IV"), Cormorant Private Healthcare Fund V, LP ("Fund V") and a managed account (the "Account"). Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC serve as the general partners of the Master Fund, Fund III, Fund IV and Fund V, respectively. Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC, and the general partner of Cormorant Asset Management, LP. |
(2) | Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose. |
(3) | Represents (i) 434,934 shares of Class A Common Stock beneficially owned by the Master Fund, (ii) 1,109,451 shares of Class A Common Stock beneficially owned by Fund III, (iii) 235,480 shares of Class A Common Stock beneficially owned by Fund IV, (iv) 49,929 shares of Class A Common Stock beneficially owned by Fund V, and (v) 7,945 shares of Class A Common Stock beneficially owned by the Account. |